Skip to main content

Table 3 Subsite distribution among cancer cases eligible for survival analysis, Estonia, 1995–2006

From: Sex differences in cancer survival in Estonia: a population-based study

    No of cases (%)  
Cancer site Subsite ICD-O-3 Men Women p-value*
Mouth, pharynx All C00–14 1395 (100) 451 (100) p < 0.001
  Lip C00 158 (11) 77 (17)  
  Tongue and oral cavity C01–06 591 (42) 203 (45)  
  Salivary glands C07–08 95 (7) 96 (21)  
  Pharynx C09–13 529 (38) 70 (16)  
  Other ill-defined sites C14 22 (2) 5 (1)  
Stomach All C16 2897 (100) 2412 (100) p < 0.001
  Cardia C16.0 249 (9) 136 (6)  
  Non-cardia C16.1–16.4 1553 (54) 1308 (54)  
  Other C16.5–16.8 238 (8) 223 (9)  
  Unspecified C16.9 857 (29) 745 (31)  
Colon All C18 1974 (100) 2712 (100) p < 0.001
  Right C18.0–18.3 630 (32) 1055 (39)  
  Transverse C18.4 181 (9) 308 (11)  
  Left C18.5–18.7 1089 (55) 1263 (47)  
  Overlapping C18.8 38 (2) 29 (1)  
  Unspecified C18.9 36 (2) 57 (2)  
Rectum All C19–21 1603 (100) 1582 (100) p < 0.001
  Rectosigmoid junction C19 234 (14) 253 (16)  
  Rectum C20 1326 (83) 1229 (78)  
  Anus, anal canal C21 43 (3) 100 (6)  
Skin melanoma All C44 533 (100) 972 (100) p < 0.001
  Head and neck C44.0–44.4 74 (14) 133 (14)  
  Trunk C44.5 280 (52) 280 (29)  
  Upper limbs C44.6 54 (10) 147 (15)  
  Lower limbs C44.7 78 (15) 352 (36)  
  Overlapping, unspecified C44.8–44.9 47 (9) 60 (6)  
  1. *Chi-squared test.